Prevention: Older Women Are Not Likely to Benefit From Cervical Cancer Vaccine


February 25, 2010

The New York Times

Women older than 40 are unlikely to get much benefit from the vaccine for the virus that causes cervical cancer, a new study reports.

The vaccine for human papillomavirus, or HPV, is recommended for women up to age 26 and girls as young as 9. To determine whether older women might be protected as well, the new study looked at patterns of HPV infection as women age, said Dr. Ana Cecilia Rodríguez, the lead author of the new paper, published online Feb. 15 in The Journal of the National Cancer Institute... read more